简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-07-23 14:29 Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year
2026-07-22 15:11 Zayed Sustainability Prize’s Beyond2020 Initiative Strengthens Healthcare Resilience for Over 200,000 People in India
2026-07-22 14:43 SIAL Paris 2026: the Event That Sheds Light on and Accelerates the Global Agri-food Industry
2026-07-21 15:58 Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension
2026-07-21 15:46 HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong
2026-07-21 11:06 Clinigen Appoints Greg Skalicky as Chief Executive Officer
2026-07-20 13:44 Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
2026-07-20 10:38 Aqemia and Sanofi Expand Their Research Collaboration
2026-07-17 13:03 Crown Bioscience Joins C-Path's NAMs Developer Coalition to Advance Human-Relevant Models in Drug Development
2026-07-17 12:38 Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network
2026-07-16 10:51 Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer
2026-07-15 16:58 Neuraptive Therapeutics Licenses Innovative Bioresorbable Nerve Stimulation Technology from Washington University in St. Louis
2026-07-15 15:34 SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
2026-07-15 09:15 Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products
2026-07-15 09:11 European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation
2026-07-14 15:58 Actus Nutrition Achieves Certified B Corporation™ Status
2026-07-14 13:32 HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform
2026-07-10 10:19 First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders
2026-07-09 09:51 Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations
2026-07-08 15:29 Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

Business Wire Weibo

Press Releases

Latest Releases